SITC Cancer Immunotherapy CONNECT

Stay Current with FDA-Approved Immunotherapy Treatments
Attend an upcoming SITC Advances in Cancer Immunotherapy™ Program 


Charleston, S.C. On Feb. 1


Tucson, Ariz. on March 14

TAMPA, Fla. on March 21




SITC's Comprehensive Cancer Immunotherapy Training Program

Attend the SITC Cancer Immunotherapy Winter School on Jan. 13-17, 2020, in Houston.

Register to Attend Today


SITC's Surfaceome Workshop

Attend the SITC Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop on April 23–24, 2020, in San Diego.

Register to Attend Today

SITC Career Connections
Connecting talent seekers with job seekers at all career levels throughout the cancer immunotherapy field.

2019 SITC Logo Crop

View Regular Abstracts from SITC 2019! 
SITC's 34th Annual Meeting & Pre-Conference Programs received a record breaking number of abstracts. Now available, the SITC 2019 regular abstract supplement as published in the Journal for ImmunoTherapy of Cancer (JITC)!

New Online Patient Course Available: Understanding Cancer Immunotherapy 
Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy

NOW AVAILABLE: SITC's Guide to Managing Immunotherapy Toxicity

A new handbook from SITC for clinicians providing thorough coverage of the toxicity and management of adverse events for immune checkpoint inhibitors.

Purchase Today

2019 Lung Cancer and Immunotherapy Course 
A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now


Why I'm a SITC Member

Join Patrick Hwu, MD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member


Inspire the Next Generation of Cancer Immunotherapy Leaders

Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.

Donate Today


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • Thank you for attending the Advances in Cancer Immunotherapy™ program in Philadelphia, PA on November 12, 2019. We were pleased you could join us to take part in the education and networking opportunities this program provided. As a benefit of attending ...

    1 person recommends this.
  • Presentations from the 2019 Advances in Cancer Immunotherapy ™ – Cleveland, OH held on September 5, 2019 are now available in the SITC Resource Library. Click here to access ACI – Cleveland presentations. You can also reach these materials by clicking ...

  • Dear Steaphine, I attended the Buffalo Immunotherapy conference on October 26, along with my wife Bonnie Blum.  She has informed me that her pharmacy CE credits have been posted, however, my credits have not yet been posted. Can you let me know when ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More